Performances on the Montreal Cognitive Assessment Along the Cardiovascular Disease Continuum

Christine Gagnon1, Kathia Saillant1,2, Miloudza Olmand1,3

  • 1Preventive Medicine and Physical Activity Centre and Research Center, Montreal Heart Institute, Montreal, Canada.

Insights

The Montreal Cognitive Assessment (MoCA) detects cognitive impairment in later stages of cardiovascular disease, like heart failure, particularly in verbal fluency and memory. Earlier detection may need more detailed neuropsychological testing.

Area of Science:

  • Cardiology
  • Neurology
  • Cognitive Science

Background:

  • Cardiovascular diseases (CVD) encompass a spectrum from risk factors to heart failure, often accompanied by cognitive impairment (CI).
  • Cognitive impairment is prevalent in CVD, affecting up to 50% of heart failure patients and linked to adverse outcomes.
  • Early CI detection in CVD is crucial, with the Montreal Cognitive Assessment (MoCA) being a common screening tool.

Purpose of the Study:

  • To compare the performance of individuals across the cardiovascular disease continuum on the MoCA and its subscores.
  • To investigate the utility of the MoCA in identifying cognitive changes associated with different CVD profiles.

Main Methods:

  • Eighty participants over 50 years old were categorized into four groups: low cardiovascular risk, high cardiovascular risk, coronary heart disease, and stable heart failure.
  • Analysis of Variance (ANCOVA) was used to compare MoCA total and subscores, controlling for sex, age, and education.

Main Results:

  • Significant differences were found in MoCA total scores, with heart failure patients scoring lower than those with low cardiovascular risk.
  • Subscore analysis revealed deficits in verbal fluency (heart failure < low risk), memory (coronary heart disease < low risk), and orientation (coronary heart disease < low and high risk).

Conclusions:

  • The MoCA, especially its verbal fluency and memory components, can identify cognitive changes in advanced cardiovascular disease stages like heart failure.
  • Detecting cognitive impairment earlier in the cardiovascular disease continuum may necessitate comprehensive neuropsychological assessments beyond the MoCA.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
566
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
117
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
172
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
115